ALPHARETTA, Ga.--(BUSINESS WIRE)--SANUWAVE Health, Inc. (OTCBB: SNWV), an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today announced the appointment of Barbara M. Henagan to the Company’s Board of Directors. Ms. Henagan has more than 30 years of direct private equity investing experience. With this appointment, the Company’s Board has six members.
